Tolerability of the AERAS 402 tuberculosis vaccine in infants previously vaccinated with BCG.

Trial Profile

Tolerability of the AERAS 402 tuberculosis vaccine in infants previously vaccinated with BCG.

Completed
Phase of Trial: Phase I

Latest Information Update: 09 Sep 2014

At a glance

  • Drugs Tuberculosis vaccine (Primary)
  • Indications Tuberculosis
  • Focus Adverse reactions
  • Sponsors Aeras; Crucell
  • Most Recent Events

    • 14 Apr 2010 Status changed from not yet recruiting to active, no longer recruiting. The study is fully enrolled and dosing is ongoing, according to a Crucell media release.
    • 18 May 2009 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top